The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health
Testosterone deficiency (TD) is a common clinical condition that causes sexual and non-sexual symptoms. Low serum concentrations of testosterone also predict significant health outcomes, such as diabetes, metabolic syndrome, and increased mortality. Treatment with testosterone therapy (TTh) effectiv...
Gespeichert in:
| Veröffentlicht in: | Current urology reports 2013-12, Vol.14 (6), p.557-564 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 564 |
|---|---|
| container_issue | 6 |
| container_start_page | 557 |
| container_title | Current urology reports |
| container_volume | 14 |
| creator | Conners, William P. Morgentaler, Abraham |
| description | Testosterone deficiency (TD) is a common clinical condition that causes sexual and non-sexual symptoms. Low serum concentrations of testosterone also predict significant health outcomes, such as diabetes, metabolic syndrome, and increased mortality. Treatment with testosterone therapy (TTh) effectively improves symptoms, and also has a positive impact on body composition and bone density. Since there is no serum testosterone value that reliably identifies men who will respond to treatment from those who will not, healthcare providers must exercise clinical judgment in making the diagnosis of TD. Multiple formulations of TTh are available, each with advantages and disadvantages. Overall, TTh is relatively safe but the risks, such as erythrocytosis, makes long-term monitoring mandatory. The evidence does not support concerns regarding cardiovascular and prostate cancer risks. |
| doi_str_mv | 10.1007/s11934-013-0370-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1445911402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1445911402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-243a491feb411aff03eff163d489e4e8617bb0813a0d052e66da47ceff2decc93</originalsourceid><addsrcrecordid>eNp9kLtOwzAUhi0EouXyACzII0vAx3ZubKhcJS5LmS03OW6DUrvYCagbr8Hr8SS4CjAy2fL5_l_HHyFHwE6BsfwsAJRCJgxEwkTOknSLjCGNLxkv0u3NnecJz0U-InshvDDGGSvkLhlxUZZlBjAmi-kC6dWbbnvdNc5SbWv6oK2e4xJtR52hUwydCx16Z5FeommqBm21PqddTD7iO72Ok65BTxtLn71r3Xw91KD9-vgM9BZ12y0OyI7RbcDDn3OfPF9fTSe3yf3Tzd3k4j6phJRdwqXQsgSDMwmgjWECjYFM1LIoUWKRQT6bsQKEZjVLOWZZrWVeRYjXWFWl2CcnQ-_Ku9c-7q6WTaiwbbVF1wcFUqYlgGQ8ojCglXcheDRq5Zul9msFTG0Eq0GwioLVRrBKY-b4p76fLbH-S_wajQAfgBBHdo5evbje2_jlf1q_AZpLh3E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1445911402</pqid></control><display><type>article</type><title>The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Conners, William P. ; Morgentaler, Abraham</creator><creatorcontrib>Conners, William P. ; Morgentaler, Abraham</creatorcontrib><description>Testosterone deficiency (TD) is a common clinical condition that causes sexual and non-sexual symptoms. Low serum concentrations of testosterone also predict significant health outcomes, such as diabetes, metabolic syndrome, and increased mortality. Treatment with testosterone therapy (TTh) effectively improves symptoms, and also has a positive impact on body composition and bone density. Since there is no serum testosterone value that reliably identifies men who will respond to treatment from those who will not, healthcare providers must exercise clinical judgment in making the diagnosis of TD. Multiple formulations of TTh are available, each with advantages and disadvantages. Overall, TTh is relatively safe but the risks, such as erythrocytosis, makes long-term monitoring mandatory. The evidence does not support concerns regarding cardiovascular and prostate cancer risks.</description><identifier>ISSN: 1527-2737</identifier><identifier>EISSN: 1534-6285</identifier><identifier>DOI: 10.1007/s11934-013-0370-5</identifier><identifier>PMID: 23999611</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Erectile Dysfunction - complications ; Hormone Replacement Therapy - methods ; Humans ; Hypogonadism - complications ; Hypogonadism - diagnosis ; Hypogonadism - drug therapy ; Male ; Medicine ; Medicine & Public Health ; Metabolic Syndrome - complications ; Nephrology ; Obesity - complications ; Office Urology (N Shore ; Osteoporosis - complications ; Section Editor ; Testosterone - deficiency ; Testosterone - therapeutic use ; Urology</subject><ispartof>Current urology reports, 2013-12, Vol.14 (6), p.557-564</ispartof><rights>Springer Science+Business Media New York 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-243a491feb411aff03eff163d489e4e8617bb0813a0d052e66da47ceff2decc93</citedby><cites>FETCH-LOGICAL-c344t-243a491feb411aff03eff163d489e4e8617bb0813a0d052e66da47ceff2decc93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11934-013-0370-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11934-013-0370-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23999611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conners, William P.</creatorcontrib><creatorcontrib>Morgentaler, Abraham</creatorcontrib><title>The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health</title><title>Current urology reports</title><addtitle>Curr Urol Rep</addtitle><addtitle>Curr Urol Rep</addtitle><description>Testosterone deficiency (TD) is a common clinical condition that causes sexual and non-sexual symptoms. Low serum concentrations of testosterone also predict significant health outcomes, such as diabetes, metabolic syndrome, and increased mortality. Treatment with testosterone therapy (TTh) effectively improves symptoms, and also has a positive impact on body composition and bone density. Since there is no serum testosterone value that reliably identifies men who will respond to treatment from those who will not, healthcare providers must exercise clinical judgment in making the diagnosis of TD. Multiple formulations of TTh are available, each with advantages and disadvantages. Overall, TTh is relatively safe but the risks, such as erythrocytosis, makes long-term monitoring mandatory. The evidence does not support concerns regarding cardiovascular and prostate cancer risks.</description><subject>Erectile Dysfunction - complications</subject><subject>Hormone Replacement Therapy - methods</subject><subject>Humans</subject><subject>Hypogonadism - complications</subject><subject>Hypogonadism - diagnosis</subject><subject>Hypogonadism - drug therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Syndrome - complications</subject><subject>Nephrology</subject><subject>Obesity - complications</subject><subject>Office Urology (N Shore</subject><subject>Osteoporosis - complications</subject><subject>Section Editor</subject><subject>Testosterone - deficiency</subject><subject>Testosterone - therapeutic use</subject><subject>Urology</subject><issn>1527-2737</issn><issn>1534-6285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtOwzAUhi0EouXyACzII0vAx3ZubKhcJS5LmS03OW6DUrvYCagbr8Hr8SS4CjAy2fL5_l_HHyFHwE6BsfwsAJRCJgxEwkTOknSLjCGNLxkv0u3NnecJz0U-InshvDDGGSvkLhlxUZZlBjAmi-kC6dWbbnvdNc5SbWv6oK2e4xJtR52hUwydCx16Z5FeommqBm21PqddTD7iO72Ok65BTxtLn71r3Xw91KD9-vgM9BZ12y0OyI7RbcDDn3OfPF9fTSe3yf3Tzd3k4j6phJRdwqXQsgSDMwmgjWECjYFM1LIoUWKRQT6bsQKEZjVLOWZZrWVeRYjXWFWl2CcnQ-_Ku9c-7q6WTaiwbbVF1wcFUqYlgGQ8ojCglXcheDRq5Zul9msFTG0Eq0GwioLVRrBKY-b4p76fLbH-S_wajQAfgBBHdo5evbje2_jlf1q_AZpLh3E</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Conners, William P.</creator><creator>Morgentaler, Abraham</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health</title><author>Conners, William P. ; Morgentaler, Abraham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-243a491feb411aff03eff163d489e4e8617bb0813a0d052e66da47ceff2decc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Erectile Dysfunction - complications</topic><topic>Hormone Replacement Therapy - methods</topic><topic>Humans</topic><topic>Hypogonadism - complications</topic><topic>Hypogonadism - diagnosis</topic><topic>Hypogonadism - drug therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Syndrome - complications</topic><topic>Nephrology</topic><topic>Obesity - complications</topic><topic>Office Urology (N Shore</topic><topic>Osteoporosis - complications</topic><topic>Section Editor</topic><topic>Testosterone - deficiency</topic><topic>Testosterone - therapeutic use</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conners, William P.</creatorcontrib><creatorcontrib>Morgentaler, Abraham</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current urology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conners, William P.</au><au>Morgentaler, Abraham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health</atitle><jtitle>Current urology reports</jtitle><stitle>Curr Urol Rep</stitle><addtitle>Curr Urol Rep</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>14</volume><issue>6</issue><spage>557</spage><epage>564</epage><pages>557-564</pages><issn>1527-2737</issn><eissn>1534-6285</eissn><abstract>Testosterone deficiency (TD) is a common clinical condition that causes sexual and non-sexual symptoms. Low serum concentrations of testosterone also predict significant health outcomes, such as diabetes, metabolic syndrome, and increased mortality. Treatment with testosterone therapy (TTh) effectively improves symptoms, and also has a positive impact on body composition and bone density. Since there is no serum testosterone value that reliably identifies men who will respond to treatment from those who will not, healthcare providers must exercise clinical judgment in making the diagnosis of TD. Multiple formulations of TTh are available, each with advantages and disadvantages. Overall, TTh is relatively safe but the risks, such as erythrocytosis, makes long-term monitoring mandatory. The evidence does not support concerns regarding cardiovascular and prostate cancer risks.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23999611</pmid><doi>10.1007/s11934-013-0370-5</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1527-2737 |
| ispartof | Current urology reports, 2013-12, Vol.14 (6), p.557-564 |
| issn | 1527-2737 1534-6285 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1445911402 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Erectile Dysfunction - complications Hormone Replacement Therapy - methods Humans Hypogonadism - complications Hypogonadism - diagnosis Hypogonadism - drug therapy Male Medicine Medicine & Public Health Metabolic Syndrome - complications Nephrology Obesity - complications Office Urology (N Shore Osteoporosis - complications Section Editor Testosterone - deficiency Testosterone - therapeutic use Urology |
| title | The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men’s Health |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A10%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Evaluation%20and%20Management%20of%20Testosterone%20Deficiency:%20the%20New%20Frontier%20in%20Urology%20and%20Men%E2%80%99s%20Health&rft.jtitle=Current%20urology%20reports&rft.au=Conners,%20William%20P.&rft.date=2013-12-01&rft.volume=14&rft.issue=6&rft.spage=557&rft.epage=564&rft.pages=557-564&rft.issn=1527-2737&rft.eissn=1534-6285&rft_id=info:doi/10.1007/s11934-013-0370-5&rft_dat=%3Cproquest_cross%3E1445911402%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1445911402&rft_id=info:pmid/23999611&rfr_iscdi=true |